Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants

Important Adv Oncol. 1996:149-66.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • B-Lymphocytes / immunology
  • B-Lymphocytes / virology
  • Bone Marrow Transplantation / adverse effects*
  • Cell Transformation, Viral
  • Clinical Trials as Topic
  • Herpesviridae Infections / therapy*
  • Herpesvirus 4, Human* / immunology
  • Humans
  • Immunity, Cellular
  • Immunocompromised Host
  • Immunotherapy, Adoptive*
  • Lymphoma, B-Cell / etiology
  • Lymphoma, B-Cell / therapy*
  • Lymphoproliferative Disorders / etiology
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / therapy
  • Lymphoproliferative Disorders / virology
  • Remission Induction
  • T-Lymphocytes, Cytotoxic / immunology
  • T-Lymphocytes, Cytotoxic / transplantation*
  • Tissue Donors
  • Transplantation / adverse effects
  • Transplantation Immunology
  • Transplantation, Homologous
  • Tumor Virus Infections / therapy*